{"meta":{"query_hash":"d3882549ed88","filters":{"venue":"Journal of sickle cell disease."},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d3882549ed88","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+sickle+cell+disease."},"results":[{"id":"W4399456861","doi":"10.1093/jscdis/yoae002.019","title":"Point-of-care Diagnostic for Foetal Haemoglobin in Kids for Sickle Cell Disease in Ghana","year":2024,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Disease; Hemolysis; Pediatrics; Anemia; Logistic regression; Hemoglobin; Sickle cell anemia; Internal medicine","score_opus":0.007568973094980964,"score_gpt":0.25732766766946186,"score_spread":0.24975869457448088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399456861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840504,0.0005449359,0.000102305065,0.00015009602,0.0000092212695,0.000057311587,0.0002045556,0.0000054282095,0.0005211924],"genre_scores_gemma":[0.9986966,0.00044155627,0.00045739248,0.000120826604,0.000006970306,0.000028468708,0.00011562741,0.0000013738336,0.0001311384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994236,0.00023808751,0.00006421466,0.00008195373,0.00008808038,0.00010406482],"domain_scores_gemma":[0.9987141,0.0003451142,0.0005257803,0.000023586545,0.00018564308,0.00020590324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067674136,0.0002249174,0.00024087816,0.0004923799,0.0003061891,0.000343045,0.00042110734,0.00039272892,0.0013042607],"category_scores_gemma":[0.002467888,0.00022093873,0.00012385243,0.0004759083,0.000440381,0.00035723925,0.00036704505,0.0004206143,0.00022131001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008977791,0.00011261951,0.99259466,0.00010564602,0.000008034928,0.0010225724,0.0010147672,0.000030441028,0.00060799025,0.000032875632,0.00031858005,0.0040620686],"study_design_scores_gemma":[0.000023845529,0.0008787637,0.9881032,0.00018359313,0.000019603445,0.004205772,0.0048165964,0.00021988418,0.00043733674,0.0000319665,0.0010712917,0.000008059161],"about_ca_topic_score_codex":0.011458644,"about_ca_topic_score_gemma":0.016128134,"teacher_disagreement_score":0.011458644,"about_ca_system_score_codex":0.0008429668,"about_ca_system_score_gemma":0.0005386832,"threshold_uncertainty_score":0.022783875},"labels":[],"label_agreement":null},{"id":"W4399456880","doi":"10.1093/jscdis/yoae002.003","title":"Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD","year":2024,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Hemopexin; Medicine; Pharmacokinetics; Tolerability; Pharmacology; Haptoglobin; Hemolysis; Heme; Internal medicine; Adverse effect; Chemistry; Biochemistry","score_opus":0.005608626792478773,"score_gpt":0.25605735461372875,"score_spread":0.25044872782125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399456880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922891,0.00096275326,0.00079271337,0.0003096451,0.000065583416,0.003051134,0.0014679738,0.000072379786,0.0009887625],"genre_scores_gemma":[0.9887033,0.0009867555,0.0020923768,0.0009485148,0.00010966974,0.0031296767,0.001730646,0.000025477282,0.002273666],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995136,0.00026146515,0.000021794633,0.000077316516,0.000054334516,0.00007149961],"domain_scores_gemma":[0.99936765,0.00011119146,0.00016072154,0.000059419803,0.00007959184,0.00022143155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015201372,0.000895291,0.0011615239,0.00026411342,0.0003077554,0.00068641506,0.00053610234,0.0010610077,0.0032444457],"category_scores_gemma":[0.001273278,0.00048763698,0.00065926707,0.00025009445,0.00058375706,0.000600541,0.0002890589,0.0021213363,0.0005747317],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61885726,0.13567209,0.018090108,0.0012541376,0.0014971518,0.0005297838,0.00060672214,0.0034047049,0.1023532,0.0005442791,0.00803423,0.109156325],"study_design_scores_gemma":[0.21812958,0.75018764,0.01739333,0.00004106425,0.00040379004,0.00045843088,0.0001236949,0.0012047278,0.006845968,0.00022454547,0.0049586827,0.000028544786],"about_ca_topic_score_codex":0.0006016149,"about_ca_topic_score_gemma":0.0013247461,"teacher_disagreement_score":0.0032444457,"about_ca_system_score_codex":0.0006901967,"about_ca_system_score_gemma":0.0013525545,"threshold_uncertainty_score":0.010853827},"labels":[],"label_agreement":null},{"id":"W4399456941","doi":"10.1093/jscdis/yoae002.017","title":"PB-04 Induces HbF Expression in a Ph1b Trial in Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Fetal hemoglobin; Medicine; Cell; Disease; Immunology; Fetus; Internal medicine; Pharmacology; Biology; Pregnancy; Genetics","score_opus":0.010622130954932613,"score_gpt":0.25841083747196275,"score_spread":0.24778870651703014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399456941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888713,0.0041906172,0.00038397365,0.0008712957,0.00015246,0.0004641387,0.00093790167,0.00014339059,0.0039849663],"genre_scores_gemma":[0.9880128,0.0023676327,0.0007118309,0.0008172915,0.00008913045,0.0004432602,0.0013609015,0.000026227257,0.006170929],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99986315,0.000060044065,0.0000086762575,0.000015829788,0.000017049548,0.00003526013],"domain_scores_gemma":[0.9998084,0.000042613832,0.00002987822,0.00001163535,0.00001688831,0.0000905676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005827714,0.00031279412,0.00071507815,0.00022733277,0.00020266593,0.0005194321,0.0002251882,0.000560958,0.006092062],"category_scores_gemma":[0.00043562744,0.00017308968,0.00036562348,0.00016966165,0.0002342421,0.0001907997,0.00021008932,0.0012323733,0.00068251265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37499166,0.023028143,0.00595809,0.0018659265,0.000951212,0.0009600466,0.00044603072,0.0025204548,0.21363807,0.001299896,0.019952336,0.35438818],"study_design_scores_gemma":[0.32467252,0.54132444,0.03296097,0.00027332478,0.00096079224,0.001466924,0.00018603208,0.002939909,0.055789854,0.0009733557,0.038396392,0.000055523953],"about_ca_topic_score_codex":0.00047571756,"about_ca_topic_score_gemma":0.0015322741,"teacher_disagreement_score":0.006092062,"about_ca_system_score_codex":0.000361739,"about_ca_system_score_gemma":0.000430725,"threshold_uncertainty_score":0.02038002},"labels":[],"label_agreement":null},{"id":"W4409107174","doi":"10.1093/jscdis/yoaf012","title":"Challenges of the allosteric regulation of hemoglobin by interaction with Cys93 of the β chain for the treatment of sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Allosteric regulation; Hemoglobin; Disease; Cell; Hemoglobin variants; Chain (unit); Hemoglobin s; Computational biology; Chemistry; Medicine; Biology; Biochemistry; Internal medicine; Sickle cell anemia; Enzyme; Physics","score_opus":0.009238167147389268,"score_gpt":0.237538547827295,"score_spread":0.22830038067990574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409107174","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12457088,0.8377128,0.012841835,0.012319164,0.0012826443,0.000087565175,0.00028453761,0.00019841095,0.010702131],"genre_scores_gemma":[0.59074783,0.38582635,0.008881898,0.004726962,0.00092804903,0.00012242561,0.0003610044,0.000051299507,0.0083541665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981076,0.000072729374,0.00001608872,0.000027996812,0.000047832193,0.000024678651],"domain_scores_gemma":[0.99983716,0.000052531366,0.000033934626,0.000010885215,0.000048292917,0.00001719802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072411116,0.00018052357,0.0003735014,0.00016202341,0.00012409229,0.0004890507,0.0002975976,0.00041400045,0.0014356914],"category_scores_gemma":[0.00038016244,0.000082749444,0.00030421512,0.0001108217,0.00022973704,0.00033483928,0.0002692031,0.001012971,0.00039637164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014901877,0.00034656015,0.0013470905,0.0055157645,0.00030318022,0.0009481211,0.000371563,0.0019258547,0.5387397,0.01821684,0.019846141,0.41094908],"study_design_scores_gemma":[0.0004678452,0.0051422995,0.0032835004,0.00093309954,0.0004988672,0.0038975675,0.0004359566,0.004117205,0.26565313,0.007872604,0.70763534,0.00006262602],"about_ca_topic_score_codex":0.00029509494,"about_ca_topic_score_gemma":0.0005741981,"teacher_disagreement_score":0.0014356914,"about_ca_system_score_codex":0.00028632235,"about_ca_system_score_gemma":0.00039671172,"threshold_uncertainty_score":0.0048028827},"labels":[],"label_agreement":null},{"id":"W4411102757","doi":"10.1093/jscdis/yoaf013.015","title":"Design of the RHEMEDY Study: A Phase 2/3 Safety, Efficacy and Pharmacokinetics Study of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis","year":2025,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vaso-occlusive crisis; Pharmacokinetics; Medicine; Disease; Sickle cell anemia; Internal medicine; Pharmacology","score_opus":0.005417700442188235,"score_gpt":0.2540955144500368,"score_spread":0.24867781400784858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411102757","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95053947,0.002938749,0.0026093319,0.0011601405,0.00035964747,0.036418043,0.0033693712,0.00024902218,0.0023561604],"genre_scores_gemma":[0.93549436,0.0019837369,0.0068884054,0.0029403411,0.00045093012,0.044171184,0.0028771355,0.000101593614,0.0050921952],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998744,0.0006525068,0.000060442588,0.00020128748,0.00011990699,0.00022182456],"domain_scores_gemma":[0.9987411,0.00014179044,0.00021644785,0.00011641018,0.000153983,0.0006303406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043526446,0.0015107968,0.0026755114,0.0004905533,0.00054110674,0.0013294086,0.0010287076,0.0018376644,0.0057075145],"category_scores_gemma":[0.0018442201,0.00087004446,0.0016445474,0.00041334567,0.0012515588,0.0012427913,0.0004956207,0.003935112,0.0019045115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7323723,0.12326223,0.014339899,0.0017813351,0.0025646922,0.000634962,0.000546304,0.0026952322,0.049525727,0.0009050624,0.0076828767,0.063689396],"study_design_scores_gemma":[0.45196027,0.5238498,0.010545829,0.00005508505,0.0009318351,0.00024666483,0.00009149939,0.00107873,0.0033177289,0.00033911323,0.0075308713,0.000052650917],"about_ca_topic_score_codex":0.00060607516,"about_ca_topic_score_gemma":0.0014497063,"teacher_disagreement_score":0.0057075145,"about_ca_system_score_codex":0.0010869742,"about_ca_system_score_gemma":0.0029603606,"threshold_uncertainty_score":0.023019254},"labels":[],"label_agreement":null},{"id":"W4414783652","doi":"10.1093/jscdis/yoaf026","title":"A global overview of SCD: populations, policy limitations, and urgent need for comprehensive SCD clinical care, a systematic review","year":2025,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; University of Ottawa; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Multidisciplinary approach; MEDLINE; Grey literature; Disease; White paper; Primary care; Health policy; Newborn screening","score_opus":0.07795793030276865,"score_gpt":0.39611121111201014,"score_spread":0.3181532808092415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414783652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068465434,0.99772745,0.00007627665,0.0005566609,0.00009418487,0.00014614331,0.00050079793,0.0000040799746,0.00020966529],"genre_scores_gemma":[0.013286135,0.984453,0.00040980452,0.0009396828,0.00010996126,0.00040768067,0.00033347213,0.0000039739944,0.00005628695],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9891851,0.0040402454,0.003949456,0.0006993058,0.001780398,0.00034554338],"domain_scores_gemma":[0.95819825,0.03123757,0.005978193,0.00047263873,0.003669929,0.0004434531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015388322,0.0011695231,0.00554524,0.015564617,0.0006828874,0.0036388936,0.0013203891,0.0017380252,0.0034026692],"category_scores_gemma":[0.055267163,0.0009798729,0.0051976014,0.01599022,0.00090551167,0.0036012223,0.0019069723,0.0012105556,0.00023685218],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011097243,0.00001096726,0.0020793437,0.936248,0.005865897,0.00008165258,0.00033226958,0.00010405289,0.000070675735,0.0005199933,0.0038691338,0.05070706],"study_design_scores_gemma":[0.00010474136,0.000074030606,0.006345867,0.9451006,0.025965372,0.00027251733,0.00052599853,0.00006345043,0.000049526636,0.00043748162,0.02103816,0.000022253324],"about_ca_topic_score_codex":0.012697881,"about_ca_topic_score_gemma":0.03506892,"teacher_disagreement_score":0.015564617,"about_ca_system_score_codex":0.0045422767,"about_ca_system_score_gemma":0.016736133,"threshold_uncertainty_score":0.081382215},"labels":[],"label_agreement":null},{"id":"W4414908263","doi":"10.1093/jscdis/yoaf032","title":"A Patient-Centered, Theory Guided Approach to Examining the Barriers and Enablers to Trial Participation amongst People with Sickle Cell Disease","year":2025,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ottawa Public Health; University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Disease; Set (abstract data type); Identification (biology); Sample (material); Clinical trial; Work (physics); MEDLINE","score_opus":0.11619665483687179,"score_gpt":0.4051982736906177,"score_spread":0.2890016188537459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414908263","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33513638,0.0023875404,0.52759475,0.052958224,0.00071409874,0.05111624,0.0008232946,0.0004259254,0.028843578],"genre_scores_gemma":[0.59464854,0.0013539784,0.35721886,0.0073457295,0.00009014118,0.036496267,0.00027330566,0.000062095794,0.0025110284],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.8714489,0.11717229,0.0026742949,0.0028874755,0.0038802775,0.0019367576],"domain_scores_gemma":[0.89190733,0.086067036,0.004702453,0.0046387007,0.0089777075,0.0037066825],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.105399884,0.0013471948,0.0012712841,0.006207451,0.008233169,0.008132917,0.004476184,0.0025140988,0.004323101],"category_scores_gemma":[0.08176752,0.0012864537,0.0014825878,0.0033945371,0.01338448,0.0068830084,0.010388035,0.0062651145,0.00063668133],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018514619,0.0014883145,0.017497873,0.004771162,0.00015122493,0.00081847224,0.7745451,0.0022204972,0.0016543863,0.059835434,0.006346109,0.13048626],"study_design_scores_gemma":[0.0005843169,0.0018327675,0.011893165,0.005495702,0.000295192,0.0007488688,0.78362066,0.010791952,0.0024010984,0.12379266,0.058373813,0.00016982519],"about_ca_topic_score_codex":0.004586759,"about_ca_topic_score_gemma":0.011718131,"teacher_disagreement_score":0.8946001,"about_ca_system_score_codex":0.014026715,"about_ca_system_score_gemma":0.053407,"threshold_uncertainty_score":0.55741453},"labels":[],"label_agreement":null},{"id":"W4417011262","doi":"10.1093/jscdis/yoag020.023","title":"Etavopivat in Adolescents with Sickle Cell Disease: Emerging Safety and Efficacy Findings from the First Cohort of the Ongoing Phase 1/2 HIBISCUS Kids Study","year":2025,"lang":"en","type":"article","venue":"Journal of sickle cell disease.","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Anemia; Sickle cell anemia; Hemoglobin; Adverse effect; Cohort study; Hemolysis; Hemolytic anemia; Hemoglobinopathy","score_opus":0.004201930896008649,"score_gpt":0.23494778788620854,"score_spread":0.2307458569901999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730741,0.01853232,0.0005840387,0.00092467625,0.00009734386,0.00055406947,0.0037276288,0.00004402251,0.0024618816],"genre_scores_gemma":[0.98314536,0.008234475,0.0013319732,0.0013417262,0.00016983679,0.0007352643,0.0040227096,0.000021536775,0.0009971176],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993698,0.00030461833,0.000044976434,0.00008945793,0.00011340573,0.00007765497],"domain_scores_gemma":[0.9981122,0.00043854484,0.00059629296,0.00009454514,0.00032029566,0.00043809233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028927594,0.00034174437,0.0009849083,0.00016022069,0.00029646375,0.0008956724,0.00031981984,0.00048121857,0.0016904781],"category_scores_gemma":[0.0018573295,0.000165437,0.00084684044,0.00024668121,0.00034871543,0.0004538744,0.00030414638,0.0013576878,0.00025721604],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31617665,0.010854844,0.30502924,0.0034667584,0.0062772864,0.0008127439,0.001039316,0.0011740106,0.032354906,0.0011853202,0.01742718,0.30420172],"study_design_scores_gemma":[0.15864898,0.21263772,0.55392915,0.0010808744,0.007964663,0.0030188344,0.000928605,0.0019773594,0.009336733,0.0010500575,0.049307566,0.00011946032],"about_ca_topic_score_codex":0.0010876309,"about_ca_topic_score_gemma":0.0025587245,"teacher_disagreement_score":0.0028927594,"about_ca_system_score_codex":0.0004893053,"about_ca_system_score_gemma":0.0009354692,"threshold_uncertainty_score":0.015298545},"labels":[],"label_agreement":null}]}